Added to YB: 2025-01-27
Pitch date: 2025-01-24
MBX.TO [neutral]
Microbix Biosystems Inc.
-49.48%
current return
Author Info
Company Info
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
Market Cap
CAD 67.8M
Pitch Price
CAD 0.48
Price Target
N/A
Dividend
N/A
EV/EBITDA
11.38
P/E
19.42
EV/Sales
2.41
Sector
Biotechnology
Category
growth
5 Microcaps in 5 Minutes - Microbix Biosystems Inc.
MBX.TO (quick overview): CA$68M mkt cap, P/E '24: 16. Antigens & QAPs for labs. QAPs grew to CA$7M rev in 6 yrs. Kinlytic drug rights, CA$4M milestones in FY24, potential CA$15M annual royalties post-2027 launch. Core biz 20%+ growth expected, antigen segment +45% in FY24. Strong Asia demand.
Read full article (1 min)